Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank:DB05901_nanopub.RA5Pbd9J1UnwLtGb4WNoPdwmlA-qzqhI7HgM1RR-NYPXI#assertion>. }
Showing items 1 to 12 of
12
with 100 items per page.
- drugbank:DB05901 type drugbank_vocabulary:Drug assertion.
- drugbank:DB05901 label "ABR-215757 [drugbank:DB05901]" assertion.
- drugbank:DB05901 seeAlso DB05901 assertion.
- drugbank:DB05901 description "ABR-215757 is developed for the treatment of SLE (Systemic Lupus Erythematosus), which is an autoimmune disease. The disease affects mainly women of fertile age and progresses in flares with relatively symptom free periods in between. Current treatments of SLE are NSAID (nonsteroidal anti-inflammatory drugs), corticosteroids, antimalarians or cytotoxic drugs like for example Cyclophosphamide. The autoimmune attack affects several different organ systems and many patients suffer from serious secondary disease symptoms such as renal disorders as the disease progresses." assertion.
- drugbank:DB05901 identifier "drugbank:DB05901" assertion.
- drugbank:DB05901 title "ABR-215757" assertion.
- drugbank:DB05901 drugbank_vocabulary:x-cas cas: assertion.
- drugbank:DB05901 drugbank_vocabulary:drugbank-id "DB05901" assertion.
- drugbank:DB05901 bio2rdf_vocabulary:x-identifiers.org DB05901 assertion.
- drugbank:DB05901 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB05901" assertion.
- drugbank:DB05901 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB05901 bio2rdf_vocabulary:identifier "DB05901" assertion.